(Q39506455)

12 September 2017

Efficacy of gemtuzumab ozogamicin on ATRA- and arsenic-resistant acute promyelocytic leukemia (APL) cells (English)

1 reference

acute promyelocytic leukemia

12 September 2017

1 reference

1 reference

A Takeshita

1

1 reference

12 September 2017

K Shinjo

2

1 reference

12 September 2017

K Naito

3

1 reference

12 September 2017

H Matsui

4

1 reference

12 September 2017

N Sahara

5

1 reference

12 September 2017

K Shigeno

6

1 reference

12 September 2017

T Horii

7

1 reference

12 September 2017

N Shirai

8

1 reference

12 September 2017

M Maekawa

9

1 reference

12 September 2017

K Ohnishi

10

1 reference

12 September 2017

T Naoe

11

1 reference

12 September 2017

R Ohno

12

1 reference

12 September 2017

1 August 2005

1 reference

12 September 2017

1 reference

12 September 2017

19

1 reference

12 September 2017

8

1 reference

12 September 2017

1306-1311

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403807

12 September 2017

0 references

cites work

Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403807

Multidrug-resistance phenotype and clinical responses to gemtuzumab ozogamicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403807

Calicheamicin-conjugated humanized anti-CD33 monoclonal antibody (gemtuzumab zogamicin, CMA-676) shows cytocidal effect on CD33-positive leukemia cell lines, but is inactive on P-glycoprotein-expressing sublines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403807

Reduced effect of gemtuzumab ozogamicin (CMA-676) on P-glycoprotein and/or CD34-positive leukemia cells and its restoration by multidrug resistance modifiers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403807

Experience with gemtuzumab ozogamycin ("mylotarg") and all-trans retinoic acid in untreated acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403807

Gemtuzumab ozogamicin (Mylotarg) as a single agent for molecularly relapsed acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403807

Retinoic acid resistance in acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403807

All-trans retinoic acid down-regulates prion protein expression independently of granulocyte maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403807

Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403807

Role of P-glycoprotein in all-trans retinoic acid (ATRA) resistance in acute promyelocytic leukaemia cells: analysis of intracellular concentration of ATRA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403807

P-glycoprotein (P-gp) and multidrug resistance-associated protein 1 (MRP1) are induced by arsenic trioxide (As(2)O(3)), but are not the main mechanism of As(2)O(3)-resistance in acute promyelocytic leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403807

Treatment of acute promyelocytic leukemia: strategy toward further increase of cure rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403807

Arsenic trioxide sensitivity is associated with low level of glutathione in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403807

Multidrug resistance protein attenuates gemtuzumab ozogamicin-induced cytotoxicity in acute myeloid leukemia cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403807

21 January 2018

Identifiers

DOI

10.1038/SJ.LEU.2403807

1 reference

Dimensions Publication ID

12 September 2017

1034357311

0 references

Fatcat ID

release_3cjed2i76bhs7brlfn6jhwpzhq

0 references

1 reference